Mesalamine Capsule, Extended Release
Product Images NDC 70771-1625

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70771-1625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mfg Label (9766ebb4 1686 4e37 B139 1866e73cf182 01)

This package contains 120 extended-release capsules of mesalamine with each capsule containing 0.375 mg of the active ingredient, USP. The medication is meant to be taken orally, and the package is child-resistant. It is essential to keep the package out of children's reach and to store it at a temperature between 15°C and 30°C (59°F and 86°F), according to USP 0.375¢ Contoled Room Temperaure guidance. The manufacturer is Cadila Healthcare L.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.